Summary
Elevance Health, Inc. (then operating as WellPoint, Inc.) filed an 8-K on June 30, 2011, to report a key change in its corporate governance. The most significant event disclosed is the election of Robert L. Dixon, Jr. to the company's Board of Directors, effective June 29, 2011. Mr. Dixon's appointment is accompanied by his inclusion on both the Audit and Governance Committees of the Board, indicating a strategic strengthening of the board's oversight capabilities. This filing suggests that the company is actively managing its board composition to ensure robust governance and compliance, which are critical factors for investor confidence.
Key Highlights
- 1Election of Robert L. Dixon, Jr. to the Board of Directors, effective June 29, 2011.
- 2Mr. Dixon's term as a director will expire at the 2014 annual shareholder meeting.
- 3Appointment of Mr. Dixon to the Audit Committee of the Board.
- 4Appointment of Mr. Dixon to the Governance Committee of the Board.
- 5The filing confirms no undisclosed arrangements or relationships requiring disclosure under Regulation S-K.
- 6Mr. Dixon will be compensated according to the company's existing director compensation program.
- 7A press release announcing the director's election is included as an exhibit.